Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research

Ankara 6200

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma, Refractory Follicular Lymphoma, Refractory Metastatic Gastric Cancer, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. — Running, not enrolling
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed